Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Heart Failure × Spironolactone × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Neoplasms 2 Obesity 1 Leukemia, Myeloid, Acute 1 Hyperandrogenism 1 Heart Failure 1 Critical Illness 1 Cardiotoxicity 1 Acute Kidney Injury 1

Interventions

Ivabradine 2 Watchful Waiting 1 Standard of Care 1 Spironolactone 1 Secondary Prevention 1 Population Groups 1 Perindopril 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Exercise 1 Control Groups 1 Blood Specimen Collection 1 Bisoprolol 1 Atorvastatin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06005259 2023-08-22

SPIROTOX

University of Sao Paulo

Phase 4 Unknown

Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡